Finance

Natalya Maisheva/iStock by Getty Pictures It has been six years since I ultimate coated Globus Medical (NYSE:GMED), believing it was time to buy the robust progress play on substantial dips. I believed that the company has been a stead grower, which confronted some headwinds on the time, as I concluded to develop right into a…